According to documents from the Hong Kong Stock Exchange, Goldman Sachs will increase its long position in Bilibili from 6.26% to 7.04%.

A top performing European fund manager who has long held Novo Nordisk signals that the hype about weight loss pills should come to an end. Since the beginning of this year, the stock price of Novo No ...